FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.
Yu M, Wu W, Sun Y, Yan H, Zhang L, Wang Z, Gong Y, Wang T, Li Q, Song J, Wang M, Zhang J, Tang Y, Zhan J, Zhang H.
Yu M, et al. Among authors: zhang l, zhang j, zhang h.
Cell Rep. 2023 Aug 29;42(8):112886. doi: 10.1016/j.celrep.2023.112886. Epub 2023 Jul 31.
Cell Rep. 2023.
PMID: 37527040
Free article.